Content about Rolaids

February 8, 2013
Sanofi: Rolaids will be relieving heartburn with its return to the market by the end of the year

During a quarterly conference call Thursday, Sanofi president global operations Hanspeter Spek noted that Sanofi's consumer arm Chattem will be relaunching the heartburn remedy Rolaids.

PARIS — During a quarterly conference call Thursday, Sanofi president of global operations Hanspeter Spek noted that Sanofi's consumer arm Chattem will be relaunching the heartburn remedy Rolaids.

"We plan to relaunch the product, which has been absent of the American markets for production problems on the side of J&J," he told analysts. "We intend to launch the product by the end of 2013, which will further accelerate the performance of Chattem in the United States."

January 7, 2013
Chattem acquires Rolaids brand from McNeil

Sanofi announced that its U.S. Consumer Healthcare Division Chattem, completed the acquisition of the worldwide rights to the Rolaids brand from McNeil Consumer Healthcare for an undisclosed amount.

PARIS — Sanofi on Monday announced that its U.S. Consumer Healthcare Division Chattem, completed the acquisition of the worldwide rights to the Rolaids brand from McNeil Consumer Healthcare for an undisclosed amount.

March 31, 2011
Report: Mutchler to lead McNeil

Johnson & Johnson on April 4 will install Pat Mutchler as head of the McNeil Consumer Healthcare unit, according to a Wednesday evening Associated Press report.

NEW YORK — Johnson & Johnson on April 4 will install Pat Mutchler as head of the McNeil Consumer Healthcare unit, according to a Wednesday evening Associated Press report.

According to the report, Johnson & Johnson said the changes will allow the company to "give focused attention to quality and compliance, and the critical task of restoring McNeil Consumer Healthcare brands."

January 14, 2011
McNeil issues recall at wholesaler level

In consultation with the Food and Drug Administration, McNeil Consumer Healthcare on Friday voluntarily recalled certain lots of Tylenol 8 Hour, Tylenol Arthritis Pain and Tylenol upper respiratory products, as well as certain lots of Benadryl, Sudafed PE and Sinutab products at the wholesale level.

FORT WASHINGTON, Pa. — In consultation with the Food and Drug Administration, McNeil Consumer Healthcare on Friday voluntarily recalled certain lots of Tylenol 8 Hour, Tylenol Arthritis Pain and Tylenol upper respiratory products, as well as certain lots of Benadryl, Sudafed PE and Sinutab products at the wholesale level.

December 10, 2010
McNeil issues voluntary recall of Rolaids products

McNeil Consumer Healthcare on Thursday voluntarily recalled all lots of Rolaids Extra Strength Softchews, Rolaids Extra Strength Plus Gas Softchews and Rolaids Multisymptom Plus Antigas Softchews distributed in the United States. McNeil is taking this action following some consumer reports of foreign materials in the product, including metal and wood particles.

FORT WASHINGTON, Pa. — McNeil Consumer Healthcare on Thursday voluntarily recalled all lots of Rolaids Extra Strength Softchews, Rolaids Extra Strength Plus Gas Softchews and Rolaids Multisymptom Plus Antigas Softchews distributed in the United States. McNeil is taking this action following some consumer reports of foreign materials in the product, including metal and wood particles.

January 14, 2010
McNeil Consumer Healthcare recalls lots of several products

McNeil Consumer Healthcare on Friday announced a voluntary recall of certain lots of over-the-counter products...